These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31401096)

  • 1. The Risk for Sudden Cardiac Death Among Patients Living With Heart Failure and Human Immunodeficiency Virus.
    Alvi RM; Neilan AM; Tariq N; Hassan MO; Awadalla M; Zhang L; Afshar M; Rokicki A; Mulligan CP; Triant VA; Zanni MV; Neilan TG
    JACC Heart Fail; 2019 Sep; 7(9):759-767. PubMed ID: 31401096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure.
    Alvi RM; Zanni MV; Neilan AM; Hassan MZO; Tariq N; Zhang L; Afshar M; Banerji D; Mulligan CP; Rokicki A; Awadalla M; Januzzi JL; Neilan TG
    Clin Infect Dis; 2020 Aug; 71(5):1306-1315. PubMed ID: 31740919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Predictors, and Outcomes of Implantable Cardioverter-Defibrillator Discharge Among People Living With HIV.
    Alvi RM; Neilan AM; Tariq N; Awadalla M; Rokicki A; Hassan M; Afshar M; Mulligan CP; Triant VA; Zanni MV; Neilan TG
    J Am Heart Assoc; 2018 Sep; 7(18):e009857. PubMed ID: 30371221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure.
    Alvi RM; Neilan AM; Tariq N; Awadalla M; Afshar M; Banerji D; Rokicki A; Mulligan C; Triant VA; Zanni MV; Neilan TG
    J Am Coll Cardiol; 2018 Jul; 72(5):518-530. PubMed ID: 30049313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus.
    Moyers BS; Secemsky EA; Vittinghoff E; Wong JK; Havlir DV; Hsue PY; Tseng ZH
    Am J Cardiol; 2014 Apr; 113(7):1260-5. PubMed ID: 24521717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.
    Pokorney SD; Al-Khatib SM; Sun JL; Schulte P; O'Connor CM; Teerlink JR; Armstrong PW; Ezekowitz JA; Starling RC; Voors AA; Velazquez EJ; Hernandez AF; Mentz RJ
    Eur J Heart Fail; 2018 Mar; 20(3):525-532. PubMed ID: 29266564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial).
    Vaduganathan M; Patel RB; Mentz RJ; Subacius H; Chatterjee NA; Greene SJ; Ambrosy AP; Maggioni AP; Udelson JE; Swedberg K; Konstam MA; O'Connor CM; Butler J; Gheorghiade M; Zannad F
    Am J Cardiol; 2018 Jul; 122(2):255-260. PubMed ID: 29731121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of sudden cardiac death in Japanese heart failure patients: international validation of the Seattle Proportional Risk Model.
    Fukuoka R; Kohno T; Kohsaka S; Shiraishi Y; Sawano M; Abe T; Nagatomo Y; Goda A; Mizuno A; Fukuda K; Shadman R; Dardas TF; Levy WC; Yoshikawa T
    Europace; 2020 Apr; 22(4):588-597. PubMed ID: 32155253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bio-clinical approach for prediction of sudden cardiac death in outpatients with heart failure: The ST2-SCD score.
    Lupón J; Cediel G; Moliner P; de Antonio M; Domingo M; Zamora E; Núñez J; González B; Santiago-Vacas E; Santesmases J; Troya MI; Díez-Quevedo C; Boldó M; Barallat J; Bayes-Genis A
    Int J Cardiol; 2019 Oct; 293():148-152. PubMed ID: 31155333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.
    Hui SK; Sharma A; Docherty K; McMurray JJV; Pitt B; Dickstein K; Pfeffer MA; Girerd N; Rossignol P; Ferreira JP; Zannad F
    Eur Heart J Acute Cardiovasc Care; 2021 Apr; 10(2):127-131. PubMed ID: 33620418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Failure Burden by Autopsy, Guideline-Directed Medical Therapy, and ICD Utilization Among Sudden Deaths.
    Ramakrishna S; Salazar JW; Olgin JE; Moffatt E; Tseng ZH
    JACC Clin Electrophysiol; 2023 Mar; 9(3):403-413. PubMed ID: 36752450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
    Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
    JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved prediction of sudden cardiac death in patients with heart failure through digital processing of electrocardiography.
    Shiraishi Y; Goto S; Niimi N; Katsumata Y; Goda A; Takei M; Saji M; Sano M; Fukuda K; Kohno T; Yoshikawa T; Kohsaka S
    Europace; 2023 Mar; 25(3):922-930. PubMed ID: 36610062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
    Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
    Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure.
    Coiro S; Girerd N; Sharma A; Rossignol P; Tritto I; Pitt B; Pfeffer MA; McMurray JJV; Ambrosio G; Dickstein K; Moss A; Zannad F
    Eur J Heart Fail; 2019 Oct; 21(10):1248-1258. PubMed ID: 31476097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review.
    Barra S; Providência R; Narayanan K; Boveda S; Duehmke R; Garcia R; Leyva F; Roger V; Jouven X; Agarwal S; Levy WC; Marijon E
    Eur Heart J; 2020 Jun; 41(21):1976-1986. PubMed ID: 31750896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center.
    Alvi RM; Afshar M; Neilan AM; Tariq N; Hassan M; Gerber J; Awadalla M; Mulligan CP; Rokicki A; Triant VA; Zanni MV; Neilan TG
    Am Heart J; 2019 Apr; 210():39-48. PubMed ID: 30731372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.